NASDAQ:EPZM
Delisted
Epizyme Stock News
$1.47
+0 (+0%)
At Close: Nov 10, 2022
Analysts Set Expectations for Epizyme Inc's Q1 2020 Earnings (NASDAQ:EPZM)
05:50am, Monday, 06'th Apr 2020
Epizyme Inc (NASDAQ:EPZM) – Equities research analysts at Oppenheimer issued their Q1 2020 EPS estimates for Epizyme in a research note issued to investors on Wednesday, April 1st. Oppenheimer analy
The Epizyme (NASDAQ:EPZM) Share Price Is Down 24% So Some Shareholders Are Getting Worried
02:43pm, Saturday, 04'th Apr 2020
The main aim of stock picking is to find the market-beating stocks. But even the best stock picker will only win with...
Goldman Sachs Group Inc. Has $11.91 Million Stock Position in Epizyme Inc (NASDAQ:EPZM)
11:00am, Saturday, 04'th Apr 2020
Goldman Sachs Group Inc. decreased its stake in shares of Epizyme Inc (NASDAQ:EPZM) by 12.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchan
Epizyme Inc (NASDAQ:EPZM) Expected to Earn FY2024 Earnings of $0.66 Per Share
09:16am, Saturday, 04'th Apr 2020
Epizyme Inc (NASDAQ:EPZM) – Equities research analysts at Oppenheimer issued their FY2024 EPS estimates for Epizyme in a research report issued on Wednesday, April 1st. Oppenheimer analyst L. Gershe
Epizyme (NASDAQ:EPZM) Upgraded at ValuEngine
07:52am, Thursday, 02'nd Apr 2020
Epizyme (NASDAQ:EPZM) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Thursday, ValuEngine reports. Several other resear
Oppenheimer Downgrades Epizyme to Perform, Lowers Price Target to $16
12:48pm, Wednesday, 01'st Apr 2020Oppenheimer sees 26% downside in Intuitive Surgical in premarket action
11:51am, Wednesday, 01'st Apr 2020
Apellis Pharmaceuticals (NASDAQ:APLS) initiated with Strong Buy rating and $86 (221% upside) price target at Raymond James.BioXcel Therapeutics (NASDAQ:BTAI) initiated with Buy rating and $45 (101% up
Analysts Have Conflicting Sentiments on These Healthcare Companies: Orchard Therapeutics (ORTX) and Epizyme (EPZM)
10:22am, Wednesday, 01'st Apr 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Orchard Therapeutics (ORTX) and Epizyme (EPZM). Orchard
Analysts Have Conflicting Sentiments on These Healthcare Companies: Orchard Therapeutics (NASDAQ: ORTX) and Epizyme (NASDAQ: EPZM)
10:22am, Wednesday, 01'st Apr 2020
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on Orchard Therapeutics (
ORTX
–
Research Report
) and Epizyme (
EPZM
–
Research Report
).
Orchard The
Epizyme (NASDAQ:EPZM) Stock Price Down 7%
07:54am, Tuesday, 31'st Mar 2020
Epizyme Inc (NASDAQ:EPZM) shares were down 7% during mid-day trading on Monday . The stock traded as low as $16.00 and last traded at $16.53, approximately 684,825 shares changed hands during mid-day
Epizyme Inc (NASDAQ:EPZM) Receives Average Rating of "Buy" from Analysts
05:58am, Tuesday, 31'st Mar 2020
Shares of Epizyme Inc (NASDAQ:EPZM) have been given an average recommendation of “Buy” by the nine ratings firms that are currently covering the company, MarketBeat.com reports. Two investment ana
Epizyme Inc (NASDAQ:EPZM) CEO Sells $50,194.80 in Stock
10:24am, Sunday, 29'th Mar 2020
Epizyme Inc (NASDAQ:EPZM) CEO Robert B. Bazemore sold 3,285 shares of the stock in a transaction that occurred on Wednesday, March 25th. The stock was sold at an average price of $15.28, for a total t
Amalgamated Bank Has $352,000 Stake in Epizyme Inc (NASDAQ:EPZM)
08:48am, Sunday, 29'th Mar 2020
Amalgamated Bank grew its holdings in shares of Epizyme Inc (NASDAQ:EPZM) by 8.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission
Epizyme (NASDAQ:EPZM) Trading Up 16.7%
08:56am, Saturday, 28'th Mar 2020
Epizyme Inc (NASDAQ:EPZM)’s stock price shot up 16.7% during trading on Thursday . The stock traded as high as $17.81 and last traded at $17.71, 1,326,923 shares changed hands during mid-day trading
